The Surrey Heartlands Integrated Care System Area Prescribing Committee recommends galcanezumab for preventing migraine in line with NICE TA659
Galcanezumab will be has a RED traffic light status for this indication
Galcanezumab is a payment by results drug and blueteq forms for initiation and continuation will be available for specialist teams to complete.
Primary care prescribers should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication
